Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies

Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have unprecedentedly improved global prognosis in several types of cancers. However, they are associated with the occurrence of immune-related adverse events. Despite their low incidence, renal complications can interfere wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Belliere, Julie, Mazieres, Julien, Meyer, Nicolas, Chebane, Leila, Despas, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303282/
https://www.ncbi.nlm.nih.gov/pubmed/34208848
http://dx.doi.org/10.3390/diagnostics11071187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303282/
https://www.ncbi.nlm.nih.gov/pubmed/34208848
http://dx.doi.org/10.3390/diagnostics11071187

Ejemplares similares